CANCER CENTER ADMINISTRATION - ABSTRACT Administration at the Karmanos Cancer Institute (KCI) provides support to the Cancer Center leadership, Research Program and Shared Resource infrastructure, KCI membership, and staff by providing services aimed at relieving the administrative burden associated with research. Administration contributes to the mission of the Cancer Center by providing efficient management of resources, facilitating key internal and external scientific meetings, strategic planning, and developing useful metrics to aid in the decision making of KCI senior leadership. Mr. Evano Piasentin, Associate Center Director for Research Administration, leads an experienced administrative team. Administration supports 135 scientific members across four research Programs and nine Shared Resources (including one under development). Additionally, Administration manages extramural funding of $63 million (annual direct costs), KCI?s annual research budget of $21 million, and coordinated internal pilot funding of more than $2 million since the last renewal. Notable achievements during the past funding period include a restructuring of the administrative office to capitalize on the unique skills of staff and provide a more efficient and dynamic environment to meet the needs of the Cancer Center. Additionally, Administration supported the planning, process, and development of a new strategic plan through organization of strategic planning retreats convening stakeholders from various disciplines across KCI. The strategic plan is centered on five priority areas: immunology and immunotherapy, cancer metabolism and metabolomics, biology of cancer health disparities, addressing multilevel determinants of risk and survivorship, and increasing interventional research to reduce disparities. Administration continues to implement significant upgrades to the Research Administration Application (RAA), a homegrown repository of CCSG data for KCI. With respect to space management, Administration managed a relocation of basic science laboratories from the outdated Prentis Cancer Research Building to the renovated Elliman Research Building. Finally, Administration played a central role in the development of several large, multi-PI project grants leading to the first-ever funded SPORE grant at KCI; The Michigan Prostate SPORE (P50CA186786).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA022453-39
Application #
10088974
Study Section
Special Emphasis Panel (ZCA1)
Project Start
1997-08-08
Project End
2025-11-30
Budget Start
2020-12-15
Budget End
2021-11-30
Support Year
39
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Li, Feng; Wang, Yongli; Li, Dapeng et al. (2018) Perspectives on the recent developments with green tea polyphenols in drug discovery. Expert Opin Drug Discov 13:643-660
Ramseyer, Vanesa D; Kimler, Victoria A; Granneman, James G (2018) Vacuolar protein sorting 13C is a novel lipid droplet protein that inhibits lipolysis in brown adipocytes. Mol Metab 7:57-70
Healy, Mark A; Morris, Arden M; Abrahamse, Paul et al. (2018) The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program. BMC Cancer 18:481
Lacher, Sarah E; Alazizi, Adnan; Wang, Xuting et al. (2018) A hypermorphic antioxidant response element is associated with increased MS4A6A expression and Alzheimer's disease. Redox Biol 14:686-693
Alsaab, Hashem O; Sau, Samaresh; Alzhrani, Rami M et al. (2018) Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages. Biomaterials 183:280-294
Chammaa, May; Malysa, Agnes; Redondo, Carlos et al. (2018) RUMI is a novel negative prognostic marker and therapeutic target in non-small-cell lung cancer. J Cell Physiol 233:9548-9562
Vaishampayan, Ulka N; Podgorski, Izabela; Heilbrun, Lance K et al. (2018) Biomarkers and Bone Imaging Dynamics Associated with Clinical Outcomes of Oral Cabozantinib Therapy in Metastatic Castrate-Resistant Prostate Cancer. Clin Cancer Res :
Mills, Anne M; Peres, Lauren C; Meiss, Alice et al. (2018) Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES). Int J Gynecol Pathol :
Campbell, Douglas H; Lund, Maria E; Nocon, Aline L et al. (2018) Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer. PLoS One 13:e0196017
Sexton, Rachel E; Hachem, Ali H; Assi, Ali A et al. (2018) Metabotropic glutamate receptor-1 regulates inflammation in triple negative breast cancer. Sci Rep 8:16008

Showing the most recent 10 out of 826 publications